US FDA urges caution on modifying clinical studies midstream
This article was originally published in SRA
The US Food and Drug Administration's devices center says its draft guidance on adaptive designs1 for clinical studies could help medical device manufacturers cut the cost of clinical trials.
You may also be interested in...
The FAST 01 feasibility trial is evaluating a modification to Varian’s ProBeam particle accelerator that enables ultra-high dose radiation to treat cancer.
Data from the EARLY AF First, Cryo-FIRST and STOP AF trials show cryoablation is a better option than drugs for patients with symptomatic atrial fibrillation.
In this week’s podcast, Marion Webb reviews her interview with Glooko CEO Russ Johannesson and Reed Miller explains how Boston Scientific is restructuring its transcatheter aortic valve business.